The ELITE series merges artificial intelligence and augmented processing capabilities.
SonoScape Medical has launched its latest ultrasound system – the ELITE series, the company announced this week.
By combining artificial intelligence (AI) solutions and greater processing capabilities, the system is designed to improve diagnostic capabilities, company officials said.
“We developed the ELITE series in intensive cooperation with clinical experts,” said Zhou Wenping, head of research and development at SonoScape Medical. “I believe that this new series will substantially increase diagnostic confidence and empower clinicians to take advantage of the next level technologies, such as CEUS.”
SonoScape ELITE Courtesy: SonoScape Medical Corporation
This system adds AI-based automated tools, such as S-Fetus, Auto OB and lucid imaging technologies, as standard features on SonoScape’s Wis+ intelligent ultrasound platform. According to company details, the system offers four times the data processing capability and 10 times the system response rate of previous system iterations. In addition, it features advanced rendering models, including S-Live Silhouette and Color 3D.
The focus, officials said, is on optimizing image acquisition and diagnostic patient management workflows to help hospitals and clinics improve their performance, the experiences of their patients and staff, and health outcomes, while lowering the cost of care.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
What New Research Reveals About Novice Use of AI-Guided Cardiac Ultrasound
April 4th 2025In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.